Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRATEC SE Director's Dealing 2013

Dec 4, 2013

416_dirs_2013-12-04_0ae20629-41e0-4a53-a919-872d4dcbfe3c.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

News Details

Directors’ Dealings | 4 December 2013 20:05

DGAP-DD: STRATEC Biomedical AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EQS Group AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Last name: Steidle First name: Bernd M. Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: STRATEC Biomedical AG / Ordinary Share ISIN/WKN of the financial instrument: DE0007289001 Type of transaction: Sale Date: 15.11.2013 Price: 30.5655 Currency: EUR No. of items: 7500 Total amount traded: 229241.25 Place: Xetra Explanation for publication: Cashless exercise (exercising of stock options, including sale of shares by bank via Xetra marketplace; exercise price for underlying stock options: EUR 27.11 per stock option). The shares thereby sold result from stock options granted as a component of compensation. Sale as follows: date / average price / average number of items / total amount traded — 04.11.2013 / EUR 31.3021 / 515.774 / EUR 16,144.81 — 05.11.2013 / EUR 31.0312 / 788.690 / EUR 24,474.00 — 06.11.2013 / EUR 30.3998 / 1,309.524 / EUR 39,809.27 — 07.11.2013 / EUR 30.4000 / 1,235.119 / EUR 37,547.62 — 08.11.2013 / EUR 30.0084 / 705.060 / EUR 21,157.72 — 11.11.2013 / EUR 30.3083 / 312.202 / EUR 9,462.31 — 12.11.2013 / EUR 30.2964 / 401.786 / EUR 12,172.67 — 13.11.2013 / EUR 30.5470 / 238.095 / EUR 7,273.09 — 14.11.2013 / EUR 30.6971 / 1,175.595 / EUR 36,087.36 — 15.11.2013 / EUR 30.6935 / 818.155 / EUR 25,112.04. Transaction closed. Information about the company with duty of publication Issuer: STRATEC Biomedical AG Gewerbestr. 37 75217 Birkenfeld Deutschland ISIN: DE0007289001 WKN: 728900 End of Directors’ Dealings Notification (c) DGAP 04.12.2013 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 17984